Weekly Recap: NIVORZ biosimilar launch and Qdenga distribution rights
Dr. Reddy's Laboratories Ltd. Sponsored ADR (NSE:DRREDDY) launched NIVORZ, a nivolumab biosimilar cleared in India for 12 cancer indications after a 288—patient trial, and secured exclusive rights to distribute Takeda’s Qdenga dengue vaccine privately, targeting rollout after CDSCO sign—off in H1 2…